Jimmy Bechtel

Sep 18, 2024 | clinicalleader.com | Jimmy Bechtel |Stacie Bell |Erin Finot |IQVIA Biotech

Remote Services And Technology Require More Regulatory Clarity For InvestigatorsBy focusing on updating regulatory frameworks, developing technical standards, and leveraging technology for compliance, see how the industry can ensure that digital and remote trials are conducted safely and ethically. Can Optimized Cardiology Trials Solve Major Challenges?

Apr 8, 2024 | clinicalleader.com | Jimmy Bechtel |Evgeny MD |Akshay MS

Survey Reveals Barriers And Opportunities In Site SustainabilityGet a better understanding of site-level dynamics with 2024 release of the Society for Clinical Research Sites' (SCRS) Site Landscape Survey. Consider India For Your Next HCC International TrialAssess the feasibility of India as a potential venue for HCC trials as well as its epidemiology, historical perceptions, and untapped potential for international clinical research opportunities.

Mar 27, 2024 | clinicalleader.com | Jimmy Bechtel

By Jimmy Bechtel, Society for Clinical Research Sites Since its inception, the Society for Clinical Research Sites (SCRS) has been gathering data to decipher the operational health of clinical research sites. At the heart of this lies the Site Landscape Survey, providing a platform for clinical research sites to benchmark themselves against peers and for industry partners to grasp the pulse of site-level dynamics.

Feb 1, 2024 | clinicalleader.com | Abby Proch |Jimmy Bechtel

By Abby Proch, executive editor of guest columns, Clinical Leader SCOPE may be just a few weeks away, but let’s be honest: I’ve had my schedule nailed down for months. As soon as someone plopped that program (yes, a paper one!) on my desk, I combed through each page, each track, each talk, over and again until I arrived at what I hope will be the most perfectly planned and thoughtfully balanced itinerary around the Rosen Shingle Creek. Yeah, right. The more likely outcome?

Sep 27, 2023 | clinicalleader.com | Jimmy Bechtel |Lisa Spence |Carolyn Timpany

Can DCTs Be Both Patient-Centric And Financially Efficient For Sites? While DCTs have the potential to provide more convenience and improved access for patients, the anticipated cost savings touted for these trials have yet to materialize fully at the site level. In fact, the opposite has occurred in some instances.